Novo A/S as of Sept. 30, 2014
Portfolio Holdings for Novo A/S
Novo A/S holds 13 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vanguard Index Fds Total Stk Mkt (VTI) | 29.4 | $302M | 3.0M | 101.24 | |
| Ophthotech | 26.2 | $269M | 6.9M | 38.93 | |
| Vanguard Intl Equity Index F Ftse Europe Etf (VGK) | 11.3 | $116M | 2.1M | 55.22 | |
| Inogen (INGN) | 10.9 | $112M | 5.4M | 20.61 | |
| Otonomy | 5.1 | $52M | 2.2M | 24.00 | |
| Alder Biopharmaceuticals | 4.0 | $41M | 3.2M | 12.68 | |
| Akebia Therapeutics (AKBA) | 3.3 | $34M | 1.5M | 22.13 | |
| Flexion Therapeutics | 3.2 | $33M | 1.8M | 18.26 | |
| Zs Pharma | 1.9 | $20M | 507k | 39.23 | |
| Tetraphase Pharmaceuticals | 1.8 | $18M | 900k | 19.95 | |
| Tokai Pharmaceuticals | 1.5 | $16M | 1.1M | 14.44 | |
| Wright Med Group Right 03/01/2019 (Principal) | 1.0 | $10M | 4.7M | 2.15 | |
| Intersect Ent | 0.5 | $5.4M | 350k | 15.50 |
